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Abstract
Background: Imprinted genes show expression from one parental allele only and are important for development and 
behaviour. This extreme mode of allelic imbalance has been described for approximately 56 human genes. Imprinting 
status is often disrupted in cancer and dysmorphic syndromes. More subtle variation of gene expression, that is not 
parent-of-origin specific, termed 'allele-specific gene expression' (ASE) is more common and may give rise to milder 
phenotypic differences. Using two allele-specific high-throughput technologies alongside bioinformatics predictions, 
normal term human placenta was screened to find new imprinted genes and to ascertain the extent of ASE in this 
tissue.
Results: Twenty-three family trios of placental cDNA, placental genomic DNA (gDNA) and gDNA from both parents 
were tested for 130 candidate genes with the Sequenom MassArray system. Six genes were found differentially 
expressed but none imprinted. The Illumina ASE BeadArray platform was then used to test 1536 SNPs in 932 genes. The 
array was enriched for the human orthologues of 124 mouse candidate genes from bioinformatics predictions and 10 
human candidate imprinted genes from EST database mining. After quality control pruning, a total of 261 informative 
SNPs (214 genes) remained for analysis. Imprinting with maternal expression was demonstrated for the lymphocyte 
imprinted gene ZNF331 in human placenta. Two potential differentially methylated regions (DMRs) were found in the 
vicinity of ZNF331. None of the bioinformatically predicted candidates tested showed imprinting except for a skewed 
allelic expression in a parent-specific manner observed for PHACTR2, a neighbour of the imprinted PLAGL1 gene. ASE 
was detected for two or more individuals in 39 candidate genes (18%).
Conclusions: Both Sequenom and Illumina assays were sensitive enough to study imprinting and strong allelic bias. 
Previous bioinformatics approaches were not predictive of new imprinted genes in the human term placenta. ZNF331 
is imprinted in human term placenta and might be a new ubiquitously imprinted gene, part of a primate-specific locus. 
Demonstration of partial imprinting of PHACTR2 calls for re-evaluation of the allelic pattern of expression for the 
PHACTR2-PLAGL1 locus. ASE was common in human term placenta.
Background
Although diploid organisms have two copies of each
gene, they are not always equally expressed. For some
genes, only one allele is active while the other is almost
completely silenced. Two different groups of genes fall
into this category: genes that exhibit random monoallelic
expression, e.g. the odorant receptor genes and genes
coding for immunoglobulins [1,2]; and imprinted genes
that exhibit monoallelic expression in a parent-of-origin
specific manner [3]. Imprinted genes have been shown to
be important in fetal and placental development, postna-
tal growth, behaviour and metabolism [4]. Their regula-
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tion has been found to be disturbed in numerous cancers
and dysmorphic syndromes [5].
To date, 56 genes have been identified as imprinted in
humans and 98 in mice [6]. A catalogue of human
imprinted genes is kept and regularly updated at http://
igc.otago.ac.nz/home.html[7]. However, since most
imprinted have been discovered by direct approaches, the
total number of imprinted genes is not yet known.
Recently, a bioinformatics approach based on DNA
sequence characteristics of known imprinted genes pre-
dicted 600 imprinted genes in mice [8]. In the human,
statistical models have been developed to identify genes
with unequal representation of alternative alleles in the
public EST libraries, suggesting a further 55 candidate
imprinted genes [9]. Many imprinted genes are expressed
in a parent-of-origin specific manner in the placenta,
making it a "first choice" tissue in which to screen for new
imprinted genes [10].
Imprinted expression is at the extreme end of the auto-
somal allelic imbalance spectrum. However, more subtle
allelic variations around the expected 50:50 ratio of
expression have been documented. Yan et al. were the
first to report such ASE in human [11]. They studied 13
genes and detected 1.3 to 4.3-fold expression differences
between alleles for six of them. Lo et al. studied 1063
genes (using Affymetrix HuSNP array) in seven fetuses,
where of the 602 genes that were heterozygous, 326
showed preferential expression of one allele in at least
one individual (54%), while 170 (28%) showed more than
a four-fold difference between the two alleles [12]. Several
oligonucleotide microarrays have been used to study ASE
in lymphoblastoid cell lines (LCLs). Pant et al. used a cus-
tom made microarray (Perlegen, USA) and found allelic
expression differences in at least one individual in 53% of
the 1389 genes targeted by heterozygous single nucle-
otide polymorphisms (SNPs) [13]. More recently, Gimel-
brant et al. found monoallelic expression for 7.3% of the
genes they tested in clonal lymphoblastoid cells [14].
Strong ASE differences (ASE ratio >4 or <1/4) have been
found by Bjornsson et al. in 10% of SNPs in LCLs [15].
Hence, it seems that ASE is frequent, possibly underlying
much of human variability [11-15].
We have screened human term placenta for novel
imprinted genes and ASE using two technologies that
have been shown to be able to quantify allelic expression
in a medium and high-throughput manner: the MassAr-
ray system (Sequenom, Inc.) [16] and the Illumina ASE
Bead Array™[17], respectively.
Results
Sequenom
The MassArray system (Sequenom, Inc.) was used to test
143 genes for ASE in at least 23 family-trios. Each trio
consisted of placental genomic DNA (gDNA), placental
cDNA and both parental gDNAs. We analysed six
imprinted control genes, seven biallelically expressed
genes, seven orthologues of mouse imprinted genes, 99
orthologues of mouse imprinted candidate genes [8], and
26 human imprinted candidate genes [9] (Additional file
1: Supplemental Table S1). For 123 genes (86%), the
cDNA amplification was successful and at least two pla-
centas were heterozygous. A t-test (followed by FDR-
moderation) was used to verify the null hypothesis that
there was no allelic imbalance between the ratios of
alleles in gDNA and in cDNA (Table 1 and Methods).
Five imprinted control genes exhibited imprinting (no
informative sample for rs2066707-ATP10A). In the subset
of genes with acceptable cDNA genotyping success (arbi-
trarily set at a ratio between cDNA and gDNA genotyp-
ing higher than 75%, see Methods), six candidate genes
were significant for allelic imbalance in cDNA (p < 0.05)
(Table 1). None of these genes had an allelic expression
pattern that was compatible with imprinting. Of these,
RASGRF1 had the most allelic difference (76%) and it is
notable that the mouse orthologue Rasgrf1 is imprinted
in the brain [18]. Its mode of allelic expression in human
term placenta was compatible with random monoallelic
expression (no allelic preference; four paternal, one
maternal and three biallelic mode of expression; data not
shown). We checked the mode of expression of RASGFR1
in the human term placenta by Sanger sequencing. Bial-
lelic expression (with sometimes a very slight random
bias between alleles) was found in seven informative term
placenta samples (data not shown). The average fluores-
cence level of RASGFR1 on the Illumina array was below
our cut-off suggesting low expression level (see below).
We thus considered RASGRF1 random monoallelic ASE
to be a false positive.
Using rs4911163 as a readout, ACSS2 showed a statisti-
cally significant (two-tailed t-test, p = 0.0075) preferential
mode of ASE (Additional file 2). Using the Genevar data-
base (T-P. Yang and E. Dermitzakis, manuscript in prepa-
ration), variable level of expression for ACSS2 in relation
to rs4911163 genotype was also found in lymphoblastoid
cells of HapMap3 individuals (B. Stranger and E. Dermit-
zakis, manuscript in preparation; [19,20]). ACSS2  is a
cytosolic enzyme that catalyzes the activation of acetate
for use in lipid synthesis and energy generation. It has no
known function in relation to placenta.
The four other genes presented a much less convincing
ASE pattern and were probably false positives. Three of
them (DISC1, C9orf93, TF) were present on the Illumina
array (see below) and had low expression levels (average
log2 fluorescence lower than 11.25). In conclusion, the
Sequenom platform can detect ASE and imprinting, but
no new imprinted gene was found in this study.Daelemans et al. BMC Genetics 2010, 11:25
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ASE Illumina Array
To test more candidate genes, we increased our screening
throughput by using the ASE BeadArray™ (Illumina, Inc.,
USA). With this technique a total of 1536 SNPs, located
in 932 genes (214 expected to be expressed in placenta,
see Methods) (Additional file 1: Supplemental Table S2),
were tested for ASE and imprinting across 23 of the fam-
ily-trios. The candidate imprinted genes included ten
orthologues of known murine imprinted genes whose
status was unknown in human, 124 orthologues of 600
mouse candidate imprinted genes [8], ten human candi-
date imprinted genes [9], and 18 known control
imprinted genes [6,13,21] (Additional file 1: Supplemen-
tal Table S2). Genes specifically expressed in the placenta
compared to other tissues and genes differentially
expressed according to the birth weight may influence
fetal growth and so may also be imprinted. We therefore
tested 46 such genes [22]. The remaining 1179 SNPs (718
genes) on the array were chosen for unrelated research
purposes and were thus randomly selected in terms of
this study. This study also duplicated 38 genes from the
Sequenom analysis on the same samples.
Comparison of platforms
For comparison, we analysed the results obtained for the
38 genes tested on both platforms for the same family-
trios (Figure 1). These results were used to determine the
minimum cDNA intensity necessary for the Illumina
platform to correlate for ASE with the Sequenom system,
i.e. reliable Illumina allelic expression quantification. A
cDNA intensity threshold of 11.25 units (average log2 flu-
orescence) was chosen; below this value, ASE correlation
was noted to be weaker (Figure 1). The 576 SNPs with
average cDNA intensities above the threshold on the Illu-
mina arrays are listed in Additional file 1: Supplemental
Table S3.
Illumina array sensitivity for ASE detection
T o assess the capacity of the Illumina BeadArray™ ASE
platform to detect ASE, we hybridised varying propor-
Figure 1 Correlation of Sequenom and Illumina allele quantifica-
tion. Pearson's correlation coefficient (r) is calculated for the allele-spe-
cific quantification on the two platforms and plotted against cDNA 
intensity (average log2 fluorescence for the 23 placentas) on Illumina. 
The correlation drops when cDNA average intensity is lower than the 
11.25 cut-off (dashed red line).
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Table 1: SNPs and corresponding genes statistically significant when tested for ASE by Sequenom Assay.
Gene SNP_ID fdr.p.values Difference SR ratio Mode of ASE
DLK1 rs1802710 3.62E-23 88.6 0.89 Imprinting
PEG3 rs1860565 2.74E-22 98.1 1.00 Imprinting
IGF2 rs680 2.32E-16 94.6 1.04 Imprinting
PEG10 rs13073 4.19E-08 98.4 0.84 Imprinting
PHLDA2 rs13390 4.19E-08 98.1 1.13 Imprinting
DISC1 rs821616 0.022009568 15.3 0.91 Random ASE†
RASGRF1 rs11855231 0.022009568 75.7 0.95 Random mono†
C9orf93 rs1539172 0.039790941 30.0 0.78 Preferential†
TF rs8649 0.04122505 56.9 0.78 Random ASE†
ACSS2 rs4911163 0.04122505 21.9 0.86 Preferential
KIAA0523 rs3744725 0.04122505 36.5 0.96 Random ASE†
The p-value is adjusted for multiple testing (false discovery rate bound). The average difference of expression between the two alleles in the 
cDNA of heterozygous individuals is greatest for imprinted genes. SR ratio is the ratio of genotyping success rate of cDNA on gDNA. Mode of 
ASE summarises the pattern of ASE based on the quantitative allelic expression data. †False positive pattern probably due to a low expression 
level (see text for details).Daelemans et al. BMC Genetics 2010, 11:25
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tions of homozygous and heterozygous DNAs on the
array (Figures 2, 3 and Methods). These 'mixture curves'
show that this platform performs well to detect imprint-
ing and strong ASE (≥ 66-34 ratio) (mean 66-34/34-66
area under the ROC curve ≥ 0.81) but less well to detect
moderate ASE (≤ 60-40 ratio) (area under the ROC curve
≤ 0.77) (Figure 2).
Illumina array sensitivity for imprinting detection
Having demonstrated the ability of the Illumina array to
quantify strong ASE, we analysed the expression pattern
of the 18 imprinted control genes present on the array
(Table 2). To detect differential allelic expression, we
designed a statistical test (ASE test, see Methods). Being
an extreme form of ASE, we should detect imprinting
easily if the imprinted gene is sufficiently expressed in
human term placenta. Eleven imprinted control genes
had a mean cDNA intensity >11.25 units (average log2
fluorescence). Eight genes - H19 (Figure 4), PEG3, DLK1,
PLAGL1, PEG10, MEST, IGF2AS and ZNF331 (Figure 5,
see below) - displayed a pattern characteristic of imprint-
ing (parent-of-origin dependant monoallelic expression).
One imprinted control gene, GNAS, was tested by two
SNPs, rs3730171 and rs8386, which both had hybridisa-
tion intensities above 11.25. Only one placenta was
heterozygous for each of the GNAS SNPs, and those two
different placentas showed biallelic GNAS  expression
(Table 2). So, as found by others [23], GNAS  was not
imprinted in human term placenta. For PHLDA2, only
one informative trio was available and showed maternal
expression as expected (both parents were heterozygous
in the other case). IGF2R, was found to be biallelic for 13
informative samples, as expected in human term placenta
[24].
For SNPs of imprinted control genes with intensities
<11.25, the imprinting pattern became less consistent
(Table 2), confirming the value of the threshold deter-
mined by the comparison of allelic expression for genes
present on both platforms.
Figure 2 ROC plots for the mixture control data set.
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Figure 3 Log-ratios for three SNPs tested in different DNA pro-
portions of two control HapMap samples (NA12892:NA19092, 
from 0:100 to 100:0) on the Illumina ASE Beadarray. From top to 
bottom, we see SNPs that exhibit extreme allelic imbalance, interme-
diate allelic imbalance and no allelic imbalance, respectively. The first 
two examples are true positives while the last one is a true negative for 
our sensitivity and specificity analysis.
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Allele specific expression
Having established that the Illumina system could detect
imprinting and strong allelic expression imbalance, we
examined all the genes for evidence of ASE. SNPs were
considered to show statistically significant ASE if they
satisfied the following criteria: average cDNA intensity
across all samples >11.25; showed allelic imbalance in
expression according to our test (see Methods) in at least
80% of homozygous cDNA samples; and showed allelic
Figure 4 Informative samples for SNP rs2839702 (Fig. 2A) and rs2075745 (Fig. 2B) in the human H19 imprinted gene. For each informative 
(heterozygous placental genomic DNA) SNP, allelic log-ratios were plotted to compare gDNA and cDNA results. Each family trio is represented by a 
number on the X-axis and consists of placental gDNA (green), placental cDNA (purple), paternal gDNA (orange), and maternal gDNA (yellow). In the 
placental gDNA, both alleles occur almost equally and the log-ratio is close to zero. H19 is an imprinted gene. Hence in the placental cDNA, only one 
allele is expressed. The sign of the log-ratio for the cDNA sample changes depending upon the allele expressed. Imprinted genes cDNA log-ratio will 
show a typical oscillation of signal across the y-axis because it is not the allele that is important but its parent-of-origin [21]. When at least one parent 
is homozygous for the SNP under study, the parent-of-origin of the expressed allele can be ascertained. In the case of H19, the maternal allele is the 
one expressed as expected (i.e. for homozygous parents gDNA, the maternal gDNA allelic log-ratio has the same sign as the placental cDNA log-ratio 
and the paternal gDNA allelic log-ratio has the opposite sign to the placental cDNA).
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imbalance in expression according to our test (see Meth-
ods) in at least two heterozygous cDNA samples.
576 out of 1536 SNPs on the array passed the 11.25
intensity threshold indicating sufficient expression in the
term placenta for reliable ASE detection (Table 3 and
Additional file 1: Supplemental Table 3 for full list). Of
these 576 SNPs, 497 (86%) were polymorphic in our pop-
ulation for at least two individuals and so were informa-
t i v e  f o r  t h e  d e t e c t i o n  o f  A S E .  2 6 1  S N P s  p a s s e d  t h e
additional signal-based quality control criteria (see Meth-
ods and Table 3). Using our statistical test, ASE was
detected in 56 out of these 261 SNPs. Of these, 44 SNPs
Table 2: Imprinted control genes, expression threshold and analysis by our statistical ASE test on the Illumina array.
SNP ID Gene Chr Average 
intensity 
across all 
samples
Total number 
of 
heterozygous 
samples (hets)
Hets showing 
ASE: p < 0.01 
& |lfc|>0.585
Percentage 
of hets 
which show 
ASE
rs2075745 H19 11 14.01 12 12 100%
rs1860565 PEG3 19 13.63 9 9 100%
rs1802710 DLK1 14 13.57 15 14 93%
rs3730171 GNAS 20 13.54 1 0 0%†
rs2839702 H19 11 13.48 11 11 100%
rs998075 IGF2R 6 12.78 13 0 0%*
rs8100247 ZNF331 19 12.61 13 12 92%
rs9373409 PLAGL1 6 12.48 11 9 82%
rs13390 PHLDA2 11 12.33 2 2 100%
rs10863 MEST 7 12.32 4 4 100%
rs12982082 ZNF331 19 12.27 12 10 83%
rs13073 PEG10 7 12.09 11 10 91%
rs8386 GNAS 20 11.97 1 0 0%†
rs1055359 PEG3 19 11.8 10 10 100%
rs1003483 IGF2AS 11 11.32 8 7 88%
rs854541 PPP1R9A 7 11.2 13 0 0%
rs2285185 L3MBTL 20 10.97 10 1 10%
rs2171492 CPA4 7 10.57 12 0 0%
rs2071970 L3MBTL 20 10.51 11 0 0%
rs854524 PPP1R9A 7 10.41 10 0 0%
rs8234 KCNQ1 11 10.18 10 0 0%
rs1049846 PLAGL1 6 10.06 13 3 23%
rs1800504 GRB10 79 . 9 8 1 400 %
rs3741208 IGF2AS 11 9.67 10 0 0%
rs367035 SLC22A18 11 9.09 13 0 0%
rs3816800 ATP10A 15 9.09 15 0 0%
rs1570070 IGF2R 69 . 0 6 0 00 %
rs1800900 GNAS 20 8.86 9 2 22%
rs2066710 ATP10A 15 8.8 16 0 0%
Imprinted genes tested on the array are listed alongside the exonic SNP used and the intensity obtained for the cDNA (average log2 
fluorescence for the 23 placentas). The fore last column shows the number of heterozygous samples that are significant for ASE (p < 0.01) and 
that have a good probe hybridisation signal on the array (absolute log-fold change (lfc) >0.58). Examination of the last column (percentage 
of heterozygous placentas which exhibit statistically significant ASE) shows the difference for reliable detection of imprinting above or below 
the 11.25 average intensity threshold. *IGF2R is known to be biallelically expressed in human term placenta. †The two heterozygous GNAS 
placentas showed biallelic expression.Daelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
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targeted 39 candidate genes and 12 SNPs targeted nine
control imprinted genes (Table 3).
Five different types of ASE were looked for in the 44
SNPs targeting 39 genes: (1) imprinted, monoallelic
expression in a parent-of-origin dependent manner; (2)
ASE in a parent-of-origin manner, also called partial
imprinting; (3) preferential ASE, where the same allele is
expressed at higher levels in each heterozygote whatever
its parent-of-origin; (4) random monoallelic expression,
where one of the two alleles is completely silenced in a
random way; (5) random ASE, where different alleles are
expressed at higher levels in different heterozygotes with-
out parental bias (Table 4). To determine which of these
patterns of allelic imbalance in expression was detected,
log-ratios of informative family-trios were plotted as
described in Figure 4 and subjectively categorised (Addi-
tional file 3). The patterns of allelic imbalance identified
for the 56 SNPs are reported in Table 4.
For the genes exhibiting a statistically significant ASE
effect, an imprinting ASE pattern was found for all con-
trol imprinted genes and ZNF331 (encoding a zinc finger
protein on chromosome 19q13.41, RefSeq NM_018555).
Using two SNPs on the Illumina system, rs8100247 (exon
1, 5'UTR) and rs12982082 (exon 2, 5'UTR), ZNF331
showed a consistent pattern of maternal origin for the
expressed allele (Figure 5). These results strongly suggest
that the ZNF331 transcripts targeted by the SNPs present
on the array are imprinted and maternally expressed in
the human term placenta. RT-PCR amplification and
Sanger sequencing of SNPs in two exons of the ZNF331
transcript (exon 1, 5'UTR and exon 7, CDS) confirmed
the maternal expression seen with the Illumina method
(Additional file 4).
ZNF331  is thus imprinted in human term placenta.
Usually differentially methylated CpG islands are neces-
sary to achieve imprinting. The four 'promoter' CpG
islands (Figure 6) that we could find at the 5' extremity of
each isoform of ZNF331  were tested for differential
methylation. We have been able to amplify 3 CpG islands
in bisulphite-treated human term placental DNA. The
CpG 100 (promoter of ZNF331 second longest isoform)
showed a typical DMR pattern (amplicons are either fully
methylated or unmethylated). Unfortunately, no SNP was
present in the amplified regions to determine the parental
specific methylation of the DMR.
As imprinted genes are often found in clusters, we anal-
ysed the CpG island closest to ZNF331 for differential
methylation (Figure 7). We found this CpG (located
between the DPRX gene and the C19MC miRNA cluster
and called CpG 86) to show a typical DMR pattern.
Again, no SNP was available to test its parent-specific
methylation. So these data suggests that ZNF331 could be
part of a new imprinted locus with (at least) two DMRs.
The second imprinted candidate, based on our Illumina
array ASE test, is PHACTR2 (phosphatase and actin regu-
lator 2 gene). The PHACTR2  gene contains the SNP
rs1082, located in the 3'UTR of the gene, and 10 of 14
informative placentas exhibited ASE dependent on the
parent-of-origin of the allele (Figure 8). The fact that the
cDNA log-ratio is always smaller than the one seen for
homozygous gDNA suggests partial imprinting. Parental
genotyping shows that it is always the maternal allele that
is more highly expressed.
Partial imprinting of PHACTR2, was confirmed using
Sanger sequencing on fourteen placental samples. A
recurrent maternal bias was seen between gDNA and
Table 3: Summary of the DNA and cDNA genotyping for the Illumina assay.
Description Genes SNPs
A Tested on the array 932 1536
B Above intensity threshold 
(11.25)
446 576
C As in B with at least two 
heterozygous samples
393 497
D As in C with good quality 
probe hybridisation in 
homozygotes
214 261
E As in D with at least two 
heterozygotes significant for 
ASE (p < 0.01)
49 56
F As in E for the candidate genes 
only
39 (18.2%) 44 (16.9%)
Numbers of SNPs and genes that are (A) tested on the Illumina array, (B) have passed the intensity cut-off, (C) have sufficient heterozygous 
placentas, (D) have passed hybridisation probe quality controls and (E) for which our statistical test detected ASE. Column F is the same as E 
but without taking into account the imprinted control genes.Daelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
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Table 4: The ASE pattern of genes reaching statistical significance (Illumina Assay).
rsID Name Chr Imprinting 
status
Average 
intensity 
>11.25
Number of 
hets
Number of 
hets with 
p < 0.01
Pattern of ASE Alleles
rs1802710 DLK1 14 control 13.57 15 14 imprinting
rs8100247 ZNF331 19 control 12.61 13 12 imprinting
rs2075745 H19 11 control 14.01 12 12 imprinting
rs2839702 H19 11 control 13.48 11 11 imprinting
rs1082 PHACTR2 6 candidate 12.09 14 10 partial 
imprinting
rs12982082 ZNF331 19 control 12.27 12 10 imprinting
rs13073 PEG10 7 control 12.09 11 10 imprinting
rs1055359 PEG3 19 control 11.8 10 10 imprinting
rs9373409 PLAGL1 6 control 12.48 11 9 imprinting
rs1860565 PEG3 19 control 13.63 9 9 imprinting
rs2309428 TJP2 9 candidate 12.86 9 8 random ASE
rs178077 SNAP29 22 candidate 11.95 10 7 random ASE
rs1003483 IGF2AS 11 control 11.32 8 7 imprinting
rs8585 UBE2V1 20 candidate 12.36 13 6 preferential A>G
rs1130663 CD151 11 candidate 12.44 18 5 random ASE
rs4664114 FMNL2 2 candidate 11.51 14 5 random ASE
rs4944960 XRRA1 11 candidate 12.43 12 5 preferential G>C
rs2282336 TJP2 9 candidate 12.32 9 5 random ASE
rs6633 CDK2AP1 12 candidate 11.34 8 5 random ASE
rs4614 VPS11 11 candidate 13.09 13 4 random ASE
rs3817672 TFRC 3 candidate 12.07 13 4 * preferential T>C
rs2905 C14orf130 14 candidate 11.33 12 4 random ASE
rs12190287 TCF21 6 candidate 12.88 10 4 random ASE
rs3809865 ITGB3 17 candidate 12.09 10 4 random ASE
rs10863 MEST 7 control 12.32 4 4 imprinting
rs915894 NOTCH4 6 candidate 13.44 16 3 * preferential A>C
rs754615 CAST 5 candidate 13.71 14 3 preferential G>C
rs838896 SCARB1 12 candidate 12.62 10 3 random ASE
rs5758651 TCF20 22 candidate 12.4 10 3 random ASE
rs11699879 NCOA3 20 candidate 12.68 9 3 random ASE
rs838891 SCARB1 12 candidate 11.85 9 3 random ASE
rs2425009 MYH7B 20 candidate 11.68 9 3 random ASE
rs9749449 ZNF211 19 candidate 11.71 6 3 random ASE
rs4797 SQSTM1 5 candidate 14.48 18 2 preferential G>A
rs1128933 MAN2C1 15 candidate 12.71 16 2 preferential C>T
rs10277 SQSTM1 5 candidate 11.78 16 2 preferential G>A
rs2249057 NM_006031 21 candidate 13.31 13 2 * preferential C>A
rs7226091 MGC16597 17 candidate 11.83 13 2 * preferential C>G
rs1043618 HSPA1A 6 candidate 13.6 12 2 random ASE
rs17085249 ELL2 5 candidate 12.98 12 2 random ASE
rs2255255 CRNKL1 20 candidate 12.86 12 2 random ASEDaelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
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cDNA sequence traces overlapping the same PHACTR2
3'UTR SNP (rs1082) (Figure 9). These sequencing results
confirm the partial imprinting of PHACTR2 in human
term placenta and the ability of the Illumina BeadArray™
platform to detect ASE.
To examine further the strength of allelic silencing
observed in our data for all imprinted genes (i.e. complete
to partial imprinting), raw allelic values, averaged over all
cDNAs from informative individuals, were plotted for the
imprinted control genes and the most significant
imprinted candidate gene on the array (Figure 10). The
difference of expression between the two alleles of a
known imprinted gene varies from a 23-fold difference
(PEG3-rs1860565) to a 6.4-fold difference (DLK1-
rs1802710). For ZNF331, the difference is 5-fold for
rs12982082 and 11-fold for rs8100247, and for the par-
tially imprinted gene PHACTR2, 2.6-fold (Figure 10).
These results show that the repression of the silenced
allele is not complete for all control imprinted genes and
that there is a continuum from 'complete imprinting' to
'partial imprinting'. While our results could suggest that it
is likely that most or all 'completely imprinted' genes have
already been found in the placenta (see discussion), our
PHACTR2 study indicates that partially imprinted genes
could have been labelled as 'biallelic' and that several
other partially imprinted genes could still be found and
characterised.
Of the 56 SNPs (49 genes) statistically significant with
our ASE test, 12 SNPs were located in nine of our
selected imprinted control genes (DLK1, H19, IGF2AS,
MEST, PEG3, PEG10, PLAGL1, PHLDA2, ZNF331) and
one SNP was localised in PHACTR2 and its ASE pattern
was compatible with partial imprinting (see above).
Of the 43 remaining SNPs (39 genes), six (five genes)
showed an allelic preferential pattern when visually
examined (UBE2V1, XRRA1, CAST, SQSTM1, MAN2C1;
see Additional file 5) and eight showed possible allelic
preference (Table 4 and Additional file 3). The others
were too variable to be assigned a precise ASE pattern
and could correspond to random allelic bias, epistatic
allelic preferential expression, bipolar ASE (see Discus-
sion) [25] or false positives.
To investigate these 43 significant ASE SNPs further,
we used the Genevar Database (T-P. Yang and E. Dermit-
zakis, manuscript in preparation) to check for cis-effects
for the same 43 SNPs and 39 genes in LCLs from eight
HapMap3 populations (CEU, CHB, JPT, GIH, MKK, YRI,
LWK, MEX) (B. Stranger and E. Dermitzakis, manuscript
in preparation). The database allows searching for a spe-
cific SNP-gene pair showing an expression quantitative
trait locus (eQTL), for cis-eQTLs arising from a specific
SNP or for cis-eQTL SNPs acting on a specific gene
[19,20]. In other words, using this database, we can look
for the effect of a specific SNP on the transcription of a
specific gene (SNP-gene pair eQTL), the effect of a spe-
rs2013162 IRF6 1 candidate 12.64 12 2 * preferential C>A
rs11121567 PGD 1 candidate 12.03 12 2 * preferential A>G
rs3780473 ACO1 9 candidate 11.67 12 2 random ASE
rs4669 TGFBI 5 candidate 13.27 11 2 random ASE
rs7242 SERPINE1 7 candidate 13.01 11 2 random ASE
rs2788478 FLJ10300 7 candidate 13.04 10 2 random ASE
rs2271108 DOCK5 8 candidate 12.85 10 2 random ASE
rs552282 PPFIA1 11 candidate 11.58 10 2 * preferential C>T
rs1044116 NOTCH3 19 candidate 12.21 9 2 random ASE
rs7204628 MGC24665 16 candidate 11.84 9 2 random ASE
rs844 FCGR2B 1 candidate 13.05 8 2 * preferential C>T
rs11156878 KIAA0391 14 candidate 12.15 5 2 random ASE
rs12780 PRDM8 4 candidate 12.02 5 2 random ASE
rs5919 ITGB3 17 candidate 11.55 4 2 random ASE
rs13390 PHLDA2 11 control 12.33 2 2 imprinting
All SNPs had an average intensity above 11.25 and all or a subset of heterozygous samples had a significant statistical ASE test (p < 0.01). For 
each SNP, the ASE pattern (see text for details) was subjectively determined by examination of the bar charts, designed as in Figure 4, for all 
heterozygous samples. In case of preferential expression, the allele that was more expressed is indicated in the last column. *For these SNPs, 
the preferential bias is weaker.
Table 4: The ASE pattern of genes reaching statistical significance (Illumina Assay). (Continued)Daelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
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cific SNP on all (tested) genes located in the vicinity of
this SNP (SNP cis-eQTL) or we can examine the effect on
the transcription level of a specific gene by any SNPs
located in the vicinity of this gene (gene cis-eQTL). We
can also examine transcription level of a specific gene by
any tested SNPs in the vicinity of the gene (cis-effect) or
far away from the gene (trans-effect). We found respec-
tively nine, four and two of these types of eQTLs in the
database corresponding to our ASE SNPs and genes. This
suggests that 15 of our 43 ASE SNPs (35%) could be genu-
ine examples of allelic preferential expression in two dif-
ferent human tissues, namely term placenta and LCLs
[26]. Five of the 15 eQTLs were found to overlap with the
six ASE significant SNPs-genes pairs showing a promi-
nent allelic preferential bias (see Additional file 5): four
SNP-gene pair eQTLs (SQSTM1-rs10277, - rs 4797;
MAN2C1-rs1128933; CAST-rs754615) and one gene cis-
eQTL (XRRA1 (rs4944960 does not exist in Genevar)).
UBE2V1 showed only a marginal gene-eQTL effect while
rs8585 was also not in the Genevar database. So all four
SNP-gene pairs tested in both tissues and four of the five
(80%) genes showing significant preferential allelic bias in
placenta also showed a strong preferential allelic bias in
LCLs. In addition to the validation of our placental exper-
iments, this overlap strongly suggests that our most sig-
nificant preferential allelic biases (Additional file 5) are
genuine (and probably ubiquitous).
Discussion
Our data demonstrate that quantitative genotyping tech-
nologies like the Sequenom Mass Spectrometer and Illu-
mina Beadarray™ platforms are reliable in the detection of
strong allelic skewing as shown by the correct identifica-
tion of known imprinted genes and different patterns of
ASE from the data. We have found that allelic imbalances
in expression are common in the candidates we analysed
in the human term placenta and that true monoallelic
expression (imprinted or random) is a rare phenomenon.
We found only one new 'partially imprinted' gene (0.5%),
while ASE was present in 18% of the candidate genes
passing our quality control criteria. Such levels of ASE are
similar to the results seen in cell lines or other somatic
tissues [12-15,21].
Our data show that ZNF331  is imprinted in human
term placenta and expressed from the maternal allele.
ZNF331  (also known as ZNF463) was first shown to
exhibit monoallelic expression in a parent-of-origin man-
ner in lymphoblastoid cell lines [13,21], although the par-
ent-of-origin orientation of ZNF331 in these studies was
not clear (paternal in one study, maternal in the other).
No obvious explanation would easily explain this discrep-
ancy. It would be interesting to study ZNF331  allelic
mode of expression in a range of human tissues and in an
isoform-specific manner.
In addition, our methylation results (Figures 6 and 7)
suggest that ZNF331 could be part of a new imprinted
locus with (at least) two DMRs. Recently, Tsai and col-
leagues showed the same DMR pattern for the CpG 86
(the one located between DPRX and C19MC genes) inde-
pendently suggesting that the 'ZNF331-C19MC' locus
could be a new imprinted locus [27]. C19MC seems to be
mainly expressed in placenta and fetal brain [28-30], a
pattern that would perfectly suit the expression of an
imprinted gene. Finally, ZNF331 and C19MC seem to be
primate specific genes (no murine orthologue for
ZNF331 was found using Ensembl or UCSC; and C19MC
is primate-specific [28-30]). This probably explains why
this locus was not found in previous mouse genome wide
screens for imprinted loci. Hence, all aggregated results
suggest a possible importance of the ZNF331-C19MC
locus in human placental-fetal growth, metabolism and
cancer. Being primate specific genes, the determination
of their functional role in development will be a chal-
lenge.
We found PHACTR2 to be partially imprinted in pla-
centa (Figures 8 and 9). PHACTR2 is located on chromo-
some 6q24.2, 114 kb from PLAGL1 a known imprinted
gene (previously called ZAC1). Loss of imprinting of
PLAGL1 is seen in transient neonatal diabetes [31,32].
PHACTR2 is a member of a family of four actin and pro-
tein phosphatase 1 (PP1) binding proteins highly
expressed in the brain [33,34]. The function of PHACTR2
in placenta is unknown. PHACTR1, 3 and 4 have roles in
brain and neural tube development and in cell spreading
[35,36]. Mouse strain allele specific dominant expression
has been shown in brain for an isoform of Phactr3 (i.e.,
only the Phactr3 NMRI allele of exon 1C is expressed in
NMRI/Cast heterozygous F1 progeny whatever the par-
ent-of-origin of the NMRI allele) [37]. So, our results
show that PHACTR2 is partially imprinted in placenta,
and, with other work, suggest that the PHACTR  gene
family could be prone to complex epigenetic regulation.
In total across the two platforms, we experimentally
studied 183 genes identified as candidates for imprinted
expression by prior bioinformatics approaches [8,9].
Luedi et al. [8] predicted 600 genes to be imprinted out of
23,788 murine autosomal annotated genes. We have
tested 155 of these 600 mouse candidates and found one
that exhibited (partial) imprinting in the term placenta.
In another study of these murine candidates [38], one
(KCNK9) out of 16 genes selected from the 600 candi-
dates was found to be imprinted in the mouse and human
brain. Some of the 16 candidates tested by Ruf et al. [39]
were selected due to their proximity to known imprinted
genes. In our results the one gene that exhibited partial
imprinting, PHACTR2 is located adjacent to PLAGL1, a
known imprinted gene (previously called ZAC1). Com-
bined with the prior observations that imprinted genesDaelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
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often occur in clusters, these data suggest that if there are
more imprinted genes to be found they may lie close to
other imprinted genes.
Recently, Luedi and colleagues generated a list of 156
candidate human imprinted genes [40]. Given that nearly
all genes that are imprinted in human are also imprinted
in the mouse, it is surprising that the mouse and human
prediction lists overlap for only a few candidates. Non-
coding features like repeats were used to predict candi-
dates and it is possible that there were differences in the
assembly quality of these features in the versions of the
human (Ensembl version 20) and mouse (Ensembl ver-
sion 16) genomes used for these studies [8,40]. It would
be interesting to test the algorithms on the most recent
assemblies of both genomes. None of the 28 candidates
identified by mining EST databases [9] that we tested was
imprinted in placenta. Thus, only one of the 183 candi-
dates predicted by bioinformatics methods that we tested
was found (partially) imprinted in placenta. The poor
specificity of the bioinformatics predictions in placenta
raises two possibilities: either, the bioinformatics predic-
tions have low specificity overall and only a handful
Figure 5 Monoallelic maternal expression of ZNF331 as detected by two SNPs rs12982082 and rs8100247. Bar chart designed as in Figure 4.
rs12982082 ZNF331
l
o
g
2
(
(
r
a
t
i
o
s
)
)
−5
−4
−3
−2
−1
0
1
2
3
4
5
160 218 255 266 268 294 306 40 59 66 87
Placental gDNA
Placental cDNA
Father gDNA
Mother gDNA
rs8100247 ZNF331
l
o
g
2
(
(
r
a
t
i
o
s
)
)
−5
−4
−3
−2
−1
0
1
2
3
4
5
160 182 218 246 266 273 294 301 308 59 66 87 N44Daelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
Page 12 of 20
imprinted genes are still to be discovered or the predic-
tions are correctly identifying imprinting in tissues other
than placenta. Most phenotypes with a heritability com-
patible with imprinted gene disruption have been
explained [6]. However, new imprinted genes are still
being discovered:NLRP2 and OSBPL1A in placenta [15],
ZNF331  in placenta (this work) and in LCLs [13,21],
KCNK9 in brain [39,40], DLGAP2 in testis [40]. Hence it
is possible that new imprinted genes will mainly be dis-
covered in a tissue-specific manner and that more subtle
phenotypes could be associated with their disruption.
We analysed five modes of ASE (imprinted, partial
imprinting, preferential, monoallelic random, random
ASE). Recently, Cheverud and colleagues suggested that
different bipolar modes of ASE could exist [25,41]. Bipo-
lar ASE shows allele specific bias depending first on the
parent-of-origin of the allele and second on heterozygous
o r  h o m o zy g o us  s t a t u s  f o r  t h i s  a l l e l e  ( a  m od e  o f  a l l e l i c
expression inheritance that was previously only known in
the callipyge sheep [42]). Considering the bipolar associ-
ated growth and metabolic phenotypes described by
Cheverud et al. in the adult mouse [25], it will be interest-
ing to explore bipolar ASE in human tissues. However,
the platforms used in this study would need to test many
more trios with more replicates to approach the precision
required to investigate such complex ASE patterns.
Our quantitative allelic expression results for the
imprinted control genes present on the array showed that
the 'silencing' of the repressed allele is not always absolute
(Figure 10). It is more of a continuum from complete
silencing (e.g. PEG3, H19, and MEST) to partial silencing
(e.g., DLK1, IGF2AS and PHACTR2). These results agree
with the recent work of Lambertini et al, who showed
some expression of the 'silenced' allele in human term
placenta [23]. For example, for DLK1  such incomplete
silencing was present for several individuals on both the
Illumina and Sequenom platforms. We also documented
one placenta showing nearly 50-50 biallelic expression of
DLK1  (data not shown). Sakatani and colleagues have
already described such complete relaxation of imprinting
Figure 6 Methylation levels of the CpG islands within ZNF331. The figure shows the position of ZNF331 and the CpG islands in the UCSC genome 
browser. In the bottom part of the figure, the methylation pattern of the three CpG islands studied is represented. Bisulphite sequencing data was 
compiled with the BDPC webtool [53]. The blue colour indicates metylated CpGs and the yellow colour unmethylated CpGs. Each column represents 
a single CpG site and each row represents one clone. The sequences for two CpGs (45 and 83) were sorted according to their genotype.
>95% conversion rate
Haplotype A
Haplotype B
Methylated CpGs      63.3%
Unmethylated CpGs  36.7%Daelemans et al. BMC Genetics 2010, 11:25
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for IGF2 [43]. As them, we also found one term placenta
(10%) showing biallelic expression for IGF2  (data not
shown). The pathological importance of such loss of
imprinting in a 'healthy' human term placenta is not
known. Hence, our quantitative allelic expression in
imprinted genes suggest that term placenta can rarely
show complete loss of imprinting for IGF2 and DLK1,
that parent-specific allelic expression is a continuum
from complete silencing of one parental allele to a paren-
tally biased expression of the two alleles, and that some
partially imprinted genes could still be found.
Conclusion
Both Sequenom MassArray and Illumina GoldenGate
platforms were sensitive enough to study imprinting and
strong ASE (= 66-34 ratio). Four patterns of ASE
(imprinting, partial imprinting, preferential ASE, and
random ASE) were found in human term placenta. Prior
bioinformatics predictions were not useful to identify
new imprinted genes in the human term placenta, sug-
gesting that screening of other tissues and/or refinement
of prediction methods may be necessary. We showed that
ZNF331, a known lymphoblastoid cell imprinted gene, is
maternally expressed in human term placenta. The possi-
bility that ZNF331 is ubiquitously imprinted argues for
further study of its function in metabolism, behaviour,
fetal development and cancer. We showed that two
potential DMRs are present in the primate-specific
ZNF331-C19MC locus. We showed that PHACTR2, a
neighbour of the imprinted gene PLAGL1, is partially
imprinted in human placenta, the maternal allele being
m o r e  h i g h l y  e x p r e s s e d .  S u c h  a  r e s u l t  c a l l s  f o r  f u r t h e r
evaluation of the allelic expression landscape of the com-
plex and gene-rich human PHACTR2-PLAGL1  locus.
Demonstration of incomplete silencing of the repressed
allele for several control imprinted genes and PHACTR2
indicates that partially imprinted genes can be identified
with appropriate screening tools. On the Illumina array,
39 candidate genes were statistically significant for our
ASE test (18% of the candidate genes passing quality con-
trols). Finally, our results suggest that ASE is a common
Figure 7 Methylation levels of CpG86 in ZNF331 locus. The figure, generated with UCSC genome browser, indicates the position of the CpG island 
in relation to the location of ZNF331, its neighbouring genes and miRNAs. Bisulphite sequencing data was compiled with the BDPC webtool as in Fig-
ure 6. No SNP was present in the amplified sequence.
Methylated CpGs     74.1%
Unmethylated CpGs 25.9%
Conversion rate >95%
miRNA cluster (C19MC) miR371,372,373Daelemans et al. BMC Genetics 2010, 11:25
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variability factor in placental tissue and should be thor-
oughly studied in normal and pathological pregnancy.
Methods
DNA and RNA preparation
Placental trio samples consisting of placental tissues with
corresponding maternal and paternal blood samples were
collected from consenting pregnant mothers of European
ancestry at Queen Charlotte's and Chelsea Hospital (local
ethics approval 2001/6029). Samples were washed in ster-
ile PBS and snap frozen in liquid nitrogen. A set of 24
trios was randomly chosen from the tissue bank. For one
trio, the genotyping of parental DNAs revealed it was not
a biological family and parental information was removed
from subsequent analyses. Genomic DNA (gDNA) was
extracted from placental tissue samples and peripheral
blood using standard phenol-chloroform separation.
Total RNA was extracted from homogenised placental
tissues using Trizol (Invitrogen). RNA was treated with
Turbo DNA-free (Ambion) to minimize genomic DNA
contamination, concentrated and further cleaned with
RNeasy MinElute columns (Qiagen). Total RNA and
gDNA were quantified using a spectrophotometer and
either Quant-iT™ RiboGreen® RNA assay or Quant-iT™
PicoGreen® DNA assay (Invitrogen). For the Sequenom
platform, single stranded cDNA was synthesised from
250 ng of RNA with Superscript III reverse-transcriptase
(RT) (Invitrogen) and random hexamers. Duplicate sets
of samples were processed with RT omitted to detect
genomic contamination of the RNA. Both sets were
diluted at 1/50 before being assayed. For the Illumina
platform, double stranded cDNA was synthesised from
250 ng of total RNA. The first strand was synthesised
with Superscript™ III RT (Invitrogen) and randoms hex-
amers. The second strand was synthesised with DNA
polymerase I (Invitrogen) and ribonuclease H (Invitro-
gen). The 96-well plates containing the double-stranded
cDNA samples were cleaned using Multiscreen® PCRμ96
filtration plates (Millipore) before being assayed on the
Illumina ASE array.
Sequenom Assay
Control and candidate genes were selected for quantita-
tive genotyping using the homogeneous MassEXTEND
(hME) assay (Sequenom, Inc.) according to their expres-
sion levels in placenta in the Unigene database http://
www.ncbi.nlm.nih.gov/UniGene. The SNPs chosen were
located in the 5'UTR, 3'UTR, or exons and had a minor
allelic frequency (MAF) >0.15 in our population of Euro-
pean ancestry (dbSNP Build ID: 125 and 126, http://
Figure 8 rs1082 PHACTR2. The ASE pattern of rs1082-PHACTR2 is consistent with partial imprinting (maternal expression bias). Bar chart designed as 
in Figure 4.
rs1082 PHACTR2
l
o
g
2
(
(
r
a
t
i
o
s
)
)
−4
−3
−2
−1
0
1
2
3
4
103 158 160 246 255 266 268 273 294 301 40 66 N69
Placental gDNA
Placental cDNA
Father gDNA
Mother gDNADaelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
Page 15 of 20
Figure 9 PHACTR2 cDNA allelic expression ratio is biased towards the maternal allele. Sequences for rs1082 (3'UTR) of all available informative 
term placenta samples in cDNA and gDNA are shown with corresponding maternal and paternal genotyping data.
Paternal DNA
Paternal DNA
Maternal DNA
Maternal DNA
gDNA
cDNA
gDNA
cDNA
160
158 246
255
266 268
301 40
66
A/C
A/C
A/A
A/C
A/A
A/A
A/C
A/C
A/C
A/C
C/C
A/A
A/C A/C
A/A
A/A
A/C C/C
103
294
A/C
A/C
A/C
A/A
N69
A/C
A/C
90 195 47 65
gDNA
cDNA
Paternal DNA
Maternal DNA
A/C
A/A A/A
A/C C/C
A/C A/C
A/C
Technical cDNA replicates
Paternal DNA
Maternal DNA
gDNA
cDNA
Sample ID
Sample ID
Sample ID
Sample IDDaelemans et al. BMC Genetics 2010, 11:25
http://www.biomedcentral.com/1471-2156/11/25
Page 16 of 20
www.ncbi.nlm.nih.gov/SNP/. One SNP per gene was
studied for seven biallelic controls, six human imprinted
genes, seven orthologues of mouse imprinted genes, 26
human candidates [9], and 100 orthologues of mouse
candidate imprinted genes [8] (Additional file 1: Supple-
mental Table S1).
The MassArray system (Sequenom, Inc.) consists of a
primer extension assay for genotyping and quantitation
of alleles by MALDI-TOF (matrix-assisted laser desorp-
tion/ionization time-of-flight) mass spectrometry [44].
Three different primers (two for amplification and one
allele-specific MassEXTEND primer) were designed for
each targeted SNP using SpectroDesigner (Sequenom,
Inc.) within the exon or the UTRs. PCR amplification was
followed by shrimp alkaline phosphatase (SAP) treat-
ment. The primer extension reaction generates different
mass signals for the two alleles. SNPs were multiplexed in
threes according to the termination mix used. Samples
were purified using SpectroCLEAN (Sequenom). Sam-
ples were then spotted on the chip (SpectroCHIP, Seque-
nom) with the MassArray nanodispenser and analysed by
SpectroREADER mass spectrometer (Sequenom). Geno-
types were called by the proprietary software (Spectro-
Typer v2.0). Primer sequences and thermocycling
conditions are available upon request.
Sequenom analysis
To find new imprinted genes or ASE, genotype calls were
filtered to include only the genotypes that had been called
with the "conservative" rating. The percentage of geno-
typing assays called in this way for each SNP was referred
to as the success rate (SR) and was calculated for gDNA
and cDNA. The ratio of cDNA to gDNA SR was used to
filter out lowly expressed genes. Genotyping with a SR
ratio ≥ 75% was taken forward in the analysis. Calls were
then filtered to select trios with heterozygous placental
genomic DNA. On these trios, a one-tailed paired t-test
was used, for each SNP, to compare allelic quantification
of the two alleles in placental cDNA and in placental
Figure 10 Lack of complete repression of the silenced allele for imprinted genes. Average quantification of the expressed allele (dark blue) and 
of the silenced allele (light blue) in all informative samples for all expressed control imprinted genes (PEG3, H19, MEST, PEG10, PHLDA2, PLAGL1, DLK1 
and IGF2AS), for ZNF331 and for PHACTR2.
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genomic DNA. P-values were then adjusted using the
Benjamini-Hochberg method to control false discovery
rate [45]. The analysis was carried out in R [46].
Illumina Assay
The oligo pool of 1536 SNPs of the GoldenGate ASE
Array (Illumina, Inc., USA) included 18 known imprinted
genes, four housekeeping genes, 11 genes shown to be
preferentially expressed in the placenta [22], ten genes
predicted to be imprinted in humans [9], ten orthologues
of mouse imprinted genes, 35 genes that are differentially
expressed according to infant weight [22], six polycomb
genes and 124 human orthologues of genes predicted to
be imprinted in mouse [8]; all of which were selected
based on their placental expression in the Unigene data-
base http://www.ncbi.nlm.nih.gov/UniGene (see Addi-
tional file 1: Supplemental Table S2 for a list of SNPs and
genes). All SNPs chosen were located within the exons or
UTRs of the targeted genes in order to be present in the
spliced mRNA. SNPs with the highest minor allele fre-
quency (MAF) in our population in the single nucleotide
polymorphisms database (dbSNP Build ID: 125 and 126),
http://www.ncbi.nlm.nih.gov/SNP/ and best Illumina
design scores in our candidate genes were preferred.
Alleles were differentiated by Cy3 and Cy5 labelled
probes [47].
Paired gDNA (250 ng) and double-stranded cDNA
(made from 250 ng total RNA, see above) were identically
processed and hybridised to a standard 96-sample Sentrix
Array Matrix according to the manufacturer's instruc-
tions for GoldenGate genotyping assays (Illumina, Inc.,
USA) [48]. After hybridisation for 16 hours, arrays were
scanned with a Bead Station (Illumina, Inc., USA). For
each placental sample, gDNA and cDNA were assayed on
the same plate, and the whole plate analysis was repli-
cated on a different day. For two cDNA samples repli-
cates, cDNA amplification was not obtained. Parental
gDNA genotyping was performed on a separate plate (not
replicated). The genotypes were called using Illumina's
proprietary software (BeadStudio and GenCall) with the
gDNA signals as input. The composition of the trios was
imported so that Mendelian errors could be highlighted
during the manual curation of the genotyping. Arrays
with a low dynamic range were discarded and repeated.
T h e  r a w  d a t a  f r o m  t h i s  e x p e r i m e n t  i s  a v a i l a b l e  i n  t h e
ArrayExpress database http://www.ebi.ac.uk/arrayex-
press under accession number E-TABM-796.
Illumina Data Analysis
The raw Cy3 and Cy5 intensities from all beads on an
array were quantile normalised between channels. Log-
ratios (log2(Cy5/Cy3)) and average log-intensities (1/
2log2(Cy5 × Cy3)) were calculated for each bead on each
array. Outliers greater than 3 mean absolute deviations
( M A D s )  f r o m  t h e  m e d i a n  o f  e a c h  b e a d  t y p e  w e r e
removed as per Illumina's standard method and the
remaining values were averaged to obtain a summary log-
ratio and average log-intensity for each bead type (i.e.,
mean of ~30 beads per SNP) on each array. The summa-
rized data were normalised per array by median centering
the log-ratios to have median zero.
To test for ASE, we used the following method. Linear
models were fitted to the cDNA log-ratios to summarise
the replicate observations. After empirical Bayes shrink-
age of the SNP-wise variances, moderated t-statistics
were calculated [49]. Raw p-values from these t-tests
were adjusted globally for multiple testing using the
method of Benjamini and Hochberg to control the false
discovery rate [45]. Our criteria for ASE required that
SNPs satisfy the following conditions: (1) average inten-
sity across all samples greater than 11.25 (Illumina arbi-
trary fluorescence units); (2) at least 2 heterozygotes
(based on BeadStudio calls from gDNA samples) with
adjusted  p-values less than 0.01 and absolute log-fold-
changes greater than 0.585 and (3) at least 80% of
homozygotes with adjusted p-values less than 0.01 and
absolute log-fold-changes greater than 0.585. The inten-
sity cut-off was based on the concordance between Illu-
mina and Sequenom data, with probes expressed below
this level less reliably quantified on the Illumina arrays
(Figure 1). The log-fold-change cut-off of 0.585 was based
on the mixture data (Figure 2). This experiment showed
that true positives were more difficult to detect on the
Illumina arrays in mixtures at or below 60:40/40:60
(equivalent to absolute log-ratios less than log2(60/40) =
0.585). The homozygote criteria (3) ensured that the two
alleles could be reliably distinguished in the cDNA sam-
ples. All analyses were carried out in R using the beadar-
ray [50] and limma packages [51].
Mixture Analysis
For the control experiment, gDNA mixtures of two Hap-
Map individuals (NA12892:NA19092) (Coriell, Camden,
New Jersey, United States) were created in the following
proportions: 0%:100%, 5%:95%, 91%:9%, 83%:17%,
67%:33%, 64%:36%, 60%:40%, 56%:44%, 50%:50%,
44%:56%, 40%:60%, 36%:64%, 33%:67%, 17%:83%, 9%:91%,
5%:95% and 100%:0%. Each mixture was hybridized in
duplicate using the same experimental protocol. Data
were preprocessed and normalised as described in the
previous section.
A linear model was fitted to each SNP as described pre-
viously, and contrasts were obtained to give all pairwise
comparisons between a given mixture and the 50%:50%
mixture. This corrects for dye biases and systematic shifts
which are present for SNPs which are either heterozygous
and homozygous (i.e. AA:AB, BB:AB, AB:AA or AB:BB)
or have the same genotype (AA:AA, BB:BB or AB:AB) inDaelemans et al. BMC Genetics 2010, 11:25
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the two individuals. Moderated t-statistics were calcu-
lated using the empirical Bayes shrinkage procedure [49]
to test the null hypothesis that each contrast was equal to
0 (i.e. no allelic imbalance). Sensitivity and specificity cal-
culations were made for each contrast by ranking SNPs
by their log-odds and using a priori genotype information
on which SNPs are true positives/negatives for allelic
imbalance.
Genotypes for NA12892 and NA19092 were down-
loaded from HapMart http://hapmart.hapmap.org/
BioMart/martview, version 21, NCBI Build 35) for the
SNPs on the array. SNPs with known allelic imbalances
between these individuals (782), such as those which are
either homozygous and different (AA:BB or BB:AA), or
heterozygous and homozygous (AA:AB, BB:AB, AB:AA
or AB:BB), form the true positive set. SNPs which have
the same genotype for each individual (AA:AA, BB:BB or
AB:AB) should not change with mixing concentration,
and comprise the true negative set (533). SNPs with miss-
ing data (15 with NN calls) and those with IDs that could
not be found in HapMart (206) were excluded from the
analysis.
Platform Correlation
Pearson correlation coefficients were calculated for 38
SNPs using log-ratios from samples assayed using both
the Illumina arrays and Sequenom assay (log-ratios calcu-
lated as log2 [(seque_x+1)/(seque_y+1)]).
Sanger sequencing
Using Primer3 http://frodo.wi.mit.edu/, one set of prim-
ers was designed to be used for both PCR and RT-PCR.
Primer sequences and thermocycling conditions are
available upon request. PCR and RT-PCR products were
cleaned with Microclean (Microzone) and sequenced
using standard ABI sequencing technology (Big Dye
v1.1).
Methylation study
Bisulphite converted gDNA samples were prepared and
cleaned using the EZ DNA methylation-Gold™ kit (Zymo,
CA) according to the manufacturer's instructions. For
each CpG island of interest, bisulphite primers were
designed using the MethPrimer webtool http://www.uro-
gene.org/methprimer/index1.html[52]. Hotstar Taq poly-
merase (Qiagen, West Sussex, UK) was used for 45 PCR
cycles to amplify converted gDNA samples. One to three
μl of crude PCR product was ligated into pGEM®-T ® Vec-
tor System (Promega) as per manufacturer's instructions.
Ligations were then incubated at 4°C with JM109 high
efficiency competent bacterial cells (Promega) for 30
minutes. The bacterial cells were then heat shocked at
42°C for 45 seconds in a pre-heated water bath and
immediately returned on ice for 2 minutes. White colo-
nies were selected for sequencing and resuspended in 100
μl of LB-broth. The resuspended colonies were incubated
at 37°C for 1 to 2 hours. Two μl of each colony was ampli-
fied by standard PCR reaction with M13 forward and
reverse primers or the specific primers designed for the
CpG island of interest. Sequences were analysed to deter-
mine bisulphite conversion of CpG sites using Bisulphite
Sequencing DNA Methylation Analysis (BISMA) webtool
http://biochem.jacobs-university.de/BDPC/BISMA/
index.php[53].
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